Moderna entities must face infringement suits, UPC rules

UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Patent pledges in global crises: Why Moderna prevailed over Pfizer/BioNTech

10 April 2025 The Düsseldorf court’s decision offers an instructive perspective on the legal nature of patent pledges as well as a reminder that it is risky to rely solely on informal public declarations, say Ina vom Feld and Maximilian Kücking of Herbert Smith Freehills.

Unified Patent Court

Abbott v Sibio: A game-changer for UPC tech disputes

27 February 2025 The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.

Americas

Moderna wins reprieve in COVID-19 vaccine dispute

3 October 2024 Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Moderna entities must face infringement suits, UPC rules

More on this story

Editor's picks

Editor's picks

More features